Urology

Editor's Choice

Making good decisions requires that physicians have reliable and practical data. Comparative effectiveness reviews and objective findings on different medical interventions and strategies, as provided by the Agency for Healthcare Research and Quality in its Effective Health Care Program, can help physicians make the most informed choices among treatment options.

LATEST ARTICLES

Risk profiles vary for different penile surgeries, physician says

Acceptable surgery for penile enhancement should be predictably effective, low-risk and cause no harm. However, many men are undergoing cosmetic procedures that fail to meet these criteria, according to Gary Alter, M.D.

Keys to success with midurethral slings

With Ulmsen's introduction of the midurethral sling in 1996 and the procedure's subsequent refinement and redefinition, it would appear that treatment choices for a woman presenting with stress urinary incontinence (SUI) have narrowed considerably and that deciding which one to use would be easy.

Tadalafil (Cialis): A phosphodiesterase type 5 inhibitor for the treatment of benign prostatic hyperplasia

New indication: Tadalafil once-daily 5-mg oral tablet is FDA approved for the treatment of benign prostatic hyperplasia (BPH) in patients with or without erectile dysfunction (ED).

Urologists face cloud of uncertainty in 2012

Staring down a possible 27% reimbursement cut, questions about the viability of health care reform, increasing demand for their services, and a shrinking work force, it's less than surprising that urologists are anxious about the prospects for their profession.

Effective Health Care Clinician Guides